Clinical Trials
9 trialsNCT07493304 2026-05-29
ROXI-CAT-II
Regeneron Pharmaceuticals
Phase 3 Recruiting
NCT06886516 2026-04-15
Apixaban in Thrombocytopenia
Beth Israel Deaconess Medical Center
Phase EARLY_PHASE1 Recruiting
NCT05171049 2026-02-23
ASTER
Anthos Therapeutics, Inc.
Phase 3 Terminated
NCT03080883 2025-05-18
Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy
Academic and Community Cancer Research United
Phase 3 Completed
NCT02744092 2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA Completed
NCT01999179 2022-05-18
Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis
Medical College of Wisconsin
Phase NA Completed
NCT02585713 2020-08-04
Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
Academic and Community Cancer Research United
Phase 3 Completed
NCT04462003 2020-07-08
DVT
Beni-Suef University
Phase 3 Unknown
NCT02581176 2018-06-26
CAP
University Hospital, Akershus
Phase 4 Completed